FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
SILVER SPRING, Md., July 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approved TYVASO (treprostinil) Inhalation Solution for the treatment of pulmonary
NHLBI stops study of pulmonary hypertension treatment in sickle cell patients
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary
hypertension in adults with sickle cell disease nearly one year early due to safety concerns. In an interim review of safety data from 33 p...
CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week
2009 Awareness Efforts Set for August and September, PF Week Sept. 14 - 21
SAN JOSE, Calif., June 25 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) announced today it has scheduled its 2009 National Pulmonary
Fibrosis (PF) Awareness Week for September 14-21, 2009. Th...
An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market
Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources
WALTHAM, Mass., June 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmace...
New Source of Information on Pulmonary Hypertension Medications
NeedyMeds.org and the Pulmonary
Hypertension Association announce a new source of information on pulmonary
hypertension medications and the financial help available for those living with the disease.
(Vocus) June 16, 2009 -- NeedyMeds, a national nonprofit, added a ne...
CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th
"Doctor Radio" Host Interviews CPF Co-Founder, PF Advocate, and Top PF Researcher and Clinician
NEW YORK, June 15 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) today announced its co-founder and other Pulmonary
Fibrosis (PF) experts will be guests on the Sirius and XM ...
ER physicians don't follow clinical guidelines for diagnosing possible pulmonary emboli
The number of MDCT examinations for suspected pulmonary
emboli (PE) is rapidly increasing amongst ER patients, with a decrease in the number of positive studies. This may be due to a failure to adhere to established clinical guidelines for evaluating patients with suspected PE, according to a stud...
Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
CPF Recognized for Advancing Research and Patient Advocacy Efforts
SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this wee...
Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis
- Change in Forced Vital Capacity is among strongest predictors of one-year mortality -
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today reported that results of a study assessing the relationship between various measures of clinical status and the risk of d...
Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members
SAN JOSE, Calif., May 7 /PRNewswire-USNewswire/ -- The CPF today announced that the Pulmonary
Fibrosis Research Enhancement Act (PFREA) (H.R. 1079) - which would authorize $16 million in new federal funding for pulmonary
fibrosis (PF) research - has now gained the support of 27 Members of t...
Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis
NASHVILLE, Tenn., April 30 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) is pleased to announce the airing of an interview with actor James Marsden on Country Music Television (CMT)'s CMT Insider show on Saturday, May 2 at 1:30 EDT/PDT and 12:30 p.m. CDT. The interview w...
New Study Shows Long-Term Benefits for Patients with Pulmonary Arterial Hypertension
Results of a recent two-year study show promising long-term survival benefits for patients living with Pulmonary
Arterial Hypertension (PAH), a progressive, life-threatening disease in which the small blood vessels in the lungs become scarred and narrowed causing the pressure in the pulmonary
64-slice CT: Most dose efficient for evaluating pregnant patients with possible pulmonary emboli
The 64-slice CT scanner delivers the most efficient radiation dose to pregnant patients with possible pulmonary
emboli (PE) providing less risk to the fetus, according to a study performed at SUNY Stony Brook University Medical Center in Stony Brook, NY.
and pelvic studies...
Jonathan Finder, M.D., Joins Point Pleasant Pediatric Special Care's Medical Management Team as Pulmonary Consultant
ALIQUIPPA, Pa., March 23 /PRNewswire/ -- Dr. Jonathan Finder of Children's Hospital of Pittsburgh of UPMC will provide pulmonary
consulting services for Point Pleasant pediatric special care located in Aliquippa (Hopewell township), Pa. The 70 bed pediatric community opened in February 2008 and i...
CPF Launches National PSA to Educate Public on Pulmonary Fibrosis
'Target' Video Dramatizes Message That Pulmonary
Fibrosis Can Strike Anyone, Anywhere; Urges Americans to Work With CPF to Find a Cure
SAN JOSE, Calif., March 20 /PRNewswire-USNewswire/ -- Pulmonary
Fibrosis (PF) claims a life every 13 minutes in the U.S., the same number of lives each...
Oridion Receives FDA 510(k) Clearance for Capnostream(TM)20 Monitor With Integrated Pulmonary Index(TM)
JERUSALEM and NEEDHAM, Massachusetts, February 23 /PRNewswire-FirstCall/
-- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN). Oridion Systems Ltd. has
received an FDA 510(k) clearance for its Capnostream(TM)20 Monitor with
The Integrated Pulmonary
FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
ATLANTA, Feb. 17 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a
biomaterials, medical device and tissue processing company, announced today
that the U.S. Food and Drug Administration (FDA) has cleared a new claim for
the CryoValve(R) SG pulmonary
human heart valve. The new labelin...
Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards
CPF and ATS to Jointly Award $200,000 to Advance Understanding and Treatment of Pulmonary
SAN JOSE, Calif., Feb. 4 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) and the American Thoracic Society (ATS), the world's leading professional organization for pul...
Midwest Pulmonary and Critical Care Associates Will Join Aurora Medical Group
MILWAUKEE, Jan. 22 /PRNewswire/ -- Aurora Health Care announced today that
the physicians of Midwest Pulmonary
and Critical Care Associates have decided
to join Aurora Medical Group.
The physicians are Susan Darmstadter, M.D., Michael Flatley, M.D., Paul
Guzzetta, M.D., and Mark Plumb...
Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
The Center for Sleep and Pulmonary
Medicine Opens in Southwest Florida
NAPLES, Fla., Jan. 6 /PRNewswire/ -- In an effort to improve the health of patients with a wide variety of sleep and pulmonary
disorders, Mitchell L. Petusevsky, M.D., F.C.C.P. has founded The Center for Sleep and Pulmonar...
Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
SAN JOSE, Calif. Dec. 31 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) calls 2008 a year of substantial progress in advocacy, research support and awareness of a fatal disease that has no known cause, no FDA-approved treatment, and no cure - Pulmonary
Boston University School of Medicine receives a grant to study chronic obstructive pulmonary disease
(Boston)-Boston University School of Medicine (BUSM) is one of seven centers to receive a four-year grant from the National Institutes of Health (NIH) to use cutting edge genomic technologies to better understand lung disease. The $2.9 million awarded to BUSM will fund a study to probe the causes ...
CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
SAN JOSE, Calif., Dec. 3 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary
Fibrosis (CPF) today announced the launch of its newly designed patient guide offered to patients and families fighting pulmonary
fibrosis (PF), a devastating and ultimately fatal disorder characterized by progressive ...
Pulmonary Hypertension Treated with Stem Cells : International Medical Team Announces Patient Results in Adult Stem Cell Clinical Study for Pulmonary Hypertension
Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), announced nine month follow up results for the first patient treated with engineered stem cells in a clinical study of primary pulmonary
hypertension. The stem cells are extracted fro...
Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act Increases to 27 Members
SAN JOSE, Calif., Nov. 11 /PRNewswire-USNewswire/ -- The CPF today
announced that the Pulmonary
Fibrosis Research Enhancement Act (PFREA)
(H.R. 6567) - which would authorize $16 million in new federal funding for
pulmonary fibrosis (PF) research - has now gained the support of 27 Members
Women at Higher Risk for Pulmonary Hypertension
They are 4 times more apt to develop the lung artery disorder, study shows
WEDNESDAY, Oct. 29 (HealthDay News) -- Women are four times more likely to develop a debilitating and potentially lethal lung disorder known as pulmonary
hypertension, a new study shows.
Cialis May Help Ease Pulmonary Hypertension
Once-daily dose of the ED drug delayed disease progression, researchers found
WEDNESDAY, Oct. 29 (HealthDay News) -- Cialis (tadalafil), a drug used to treat erectile dysfunction, appears effective in treating pulmonary
hypertension, researchers report.
hypertension is cau...
Tomophase to Exhibit First In-vivo Cross-sectional Images of Pulmonary Stenting Using Proprietary OCT System
Results to be displayed at CHEST meeting in October
BURLINGTON, Mass., Oct. 21 /PRNewswire/ -- Tomophase Corporation
announced today that it will display the first in-vivo cross-sectional
images of implanted pulmonary
stents using their proprietary optical
coherence tomography (OCT) ...
Eisai Inc. Supports Acting Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
Support Reflects Eisai's human health care (hhc) Mission to Serve the Needs of Patients and Families
WOODCLIFF LAKE, N.J., Sept. 15 /PRNewswire/ -- Eisai Inc. announced
today its support of the Acting Surgeon General's Call to Action on venous
thromboembolism (VTE), a seri...
The U.S. Surgeon General Issues National Call-to-Action on Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
The Coalition to Prevent DVT Praises OSG in Raising Awareness of Under-recognized Condition Now Deemed a National Health Priority
Call-to-Action is an Important Step in Raising Awareness About DVT and PE
WASHINGTON, Sept. 15 /PRNewswire/ -- The Coalition to Prevent Deep-Vein
American Lung Association Commends U.S. House of Representatives for Passage of Pulmonary and Cardiac Rehabilitation Act
WASHINGTON, June 24 /PRNewswire-USNewswire/ -- The American Lung
Association commends and thanks the U.S. House of Representatives for its
passage of the Pulmonary
and Cardiac Rehabilitation Act today. As part of
the overarching Medicare Improvements for Patients and Providers Act of
Simple Case Management Cuts Pulmonary Disease Admissions
Low-intensity interventions reduce COPD hospital visits more than one-half, study finds
WEDNESDAY, May 21 (HealthDay News) -- Simple patient management can significantly reduce hospitalization and emergency room visits by people with chronic obstructive pulmonary
disease (COPD), accor...
A guided broncoscope achieves biopsy of 75 percent pulmonary nodules without puncture or surgery
The release is available in Spanish .
A broncoscope guided by means of electromagnetic navigation has managed to achieve the biopsy of 75% of pulmonary
nodules greater than 2 cm, according to Doctor Luis Seijo, specialist in Pneumology at the University Hospital of Navarra. This is the hosp...
COPD patients benefit more from pulmonary rehab in earlier stages
ATS 2008, TORONTO Patients with chronic obstructive pulmonary
disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary
rehabilitation (PR) as patients who have more years left to liveregardless of their age, complicating illnesses or lung function, accord...
New treatment gives hope for pulmonary fibrosis patients
ATS 2008, TORONTOPatients with idiopathic pulmonary
fibrosis (IPF) may have a new treatment option, according to researchers in Japan.
In a Phase III, double-blind, placebo-controlled clinical trial, the investigators discovered that a daily dose of pirfenidone could slow the progression of IPF...
Methamphetamine Use Associated With Pulmonary Arterial Hypertension in Patients With Previously Unknown Risk Factors
Hypertension Association Launches National Awareness Campaign to Raise Awareness of Methamphetamine and PAH Link -
SILVER SPRING, Md., March 20 /PRNewswire/ -- The Pulmonary
Association (PHA), in conjunction with leading pulmonary
Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry
ROCKVILLE, Md., March 3 /PRNewswire-USNewswire/ -- Adults without
symptoms of chronic obstructive pulmonary
disease (COPD) should not be
screened for the disease using spirometry, according to a new
recommendation from the U.S. Preventive Services Task Force. The
recommendation and the ac...
A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status
Although Physicians Report Satisfaction with GlaxoSmithKline's Advair and
Boehringer Ingelheim/Pfizer's Spiriva, Significant Need Remains for a Novel
Anti-Inflammatory Drug, According to a New Report from Decision Resources
WALTHAM, Mass., Feb. 27 /PRNewswire/ -- Decision Resources, one of the...
Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema
Phoenix, AZ, February 11, 2008 Researchers at Pulmonary
Associates today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally invasive option for those suff...
Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
Peoria IL., January 28, 2008 Researchers at Peoria Pulmonary
Associates today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational procedure for advanced widespread emphysema/COPD. Conducted at Meth...